Cargando…
Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis
INTRODUCTION: Systemic sclerosis (SSc) and primary biliary cirrhosis (PBC) are rare polygenic autoimmune diseases (AIDs) characterized by fibroblast dysfunction. Furthermore, both diseases share some genetic bases with other AIDs, as evidenced by autoimmune gene pleiotropism. The present study was u...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422604/ https://www.ncbi.nlm.nih.gov/pubmed/25880423 http://dx.doi.org/10.1186/s13075-015-0572-y |
_version_ | 1782370080022069248 |
---|---|
author | Arismendi, Maria Giraud, Matthieu Ruzehaji, Nadira Dieudé, Philippe Koumakis, Eugenie Ruiz, Barbara Airo, Paolo Cusi, Daniele Matucci-Cerinic, Marco Salvi, Erika Cuomo, Giovanna Hachulla, Eric Diot, Elisabeth Caramaschi, Paola Riccieri, Valeria Avouac, Jérôme Kayser, Cristiane Allanore, Yannick |
author_facet | Arismendi, Maria Giraud, Matthieu Ruzehaji, Nadira Dieudé, Philippe Koumakis, Eugenie Ruiz, Barbara Airo, Paolo Cusi, Daniele Matucci-Cerinic, Marco Salvi, Erika Cuomo, Giovanna Hachulla, Eric Diot, Elisabeth Caramaschi, Paola Riccieri, Valeria Avouac, Jérôme Kayser, Cristiane Allanore, Yannick |
author_sort | Arismendi, Maria |
collection | PubMed |
description | INTRODUCTION: Systemic sclerosis (SSc) and primary biliary cirrhosis (PBC) are rare polygenic autoimmune diseases (AIDs) characterized by fibroblast dysfunction. Furthermore, both diseases share some genetic bases with other AIDs, as evidenced by autoimmune gene pleiotropism. The present study was undertaken to investigate whether single-nucleotide polymorphisms (SNPs) identified by a large genome-wide association study (GWAS) in PBC might contribute to SSc susceptibility. METHODS: Sixteen PBC susceptibility SNPs were genotyped in a total of 1,616 patients with SSc and 3,621 healthy controls from two European populations (France and Italy). RESULTS: We observed an association between PLCL2 rs1372072 (odds ratio (OR) = 1.22, 95% confidence interval (CI) 1.12 to 1.33, P(adj) = 7.22 × 10(−5)), nuclear factor-kappa-B (NF-κB) rs7665090 (OR = 1.15, 95% CI 1.06 to 1.25, P(adj) = 0.01), and IRF8 rs11117432 (OR = 0.75, 95% CI 0.67 to 0.86, P(adj) = 2.49 × 10(−4)) with SSc susceptibility. Furthermore, phenotype stratification showed an association between rs1372072 and rs11117432 with the limited cutaneous subgroup (lcSSc) (P(adj) = 4.45 × 10(−4) and P(adj) = 0.001), whereas rs7665090 was associated with the diffuse cutaneous subtype (dcSSc) (P(adj) = 0.003). Genotype-mRNA expression correlation analysis revealed that the IRF8 protective allele was associated with increased interferon-gamma (IFN-γ) expression (P = 0.03) in patients with SSc but decreased type I IFN (IFIT1) expression in patients and controls (P = 0.02). In addition, we found an epistatic interaction between NF-κB and IRF8 (OR = 0.56, 95% CI 0.00 to 0.74, P = 4 × 10(−4)) which in turn revealed that the IRF8 protective effect is dependent on the presence of the NF-κB susceptibility allele. CONCLUSIONS: An analysis of pleiotropic genes identified two new susceptibility genes for SSc (NF-κB and PLCL2) and confirmed the IRF8 locus. Furthermore, the IRF8 variant influenced the IFN signature, and we found an interaction between IRF8 and NF-κB gene variants that might play a role in SSc susceptibility. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-015-0572-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4422604 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44226042015-05-07 Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis Arismendi, Maria Giraud, Matthieu Ruzehaji, Nadira Dieudé, Philippe Koumakis, Eugenie Ruiz, Barbara Airo, Paolo Cusi, Daniele Matucci-Cerinic, Marco Salvi, Erika Cuomo, Giovanna Hachulla, Eric Diot, Elisabeth Caramaschi, Paola Riccieri, Valeria Avouac, Jérôme Kayser, Cristiane Allanore, Yannick Arthritis Res Ther Research Article INTRODUCTION: Systemic sclerosis (SSc) and primary biliary cirrhosis (PBC) are rare polygenic autoimmune diseases (AIDs) characterized by fibroblast dysfunction. Furthermore, both diseases share some genetic bases with other AIDs, as evidenced by autoimmune gene pleiotropism. The present study was undertaken to investigate whether single-nucleotide polymorphisms (SNPs) identified by a large genome-wide association study (GWAS) in PBC might contribute to SSc susceptibility. METHODS: Sixteen PBC susceptibility SNPs were genotyped in a total of 1,616 patients with SSc and 3,621 healthy controls from two European populations (France and Italy). RESULTS: We observed an association between PLCL2 rs1372072 (odds ratio (OR) = 1.22, 95% confidence interval (CI) 1.12 to 1.33, P(adj) = 7.22 × 10(−5)), nuclear factor-kappa-B (NF-κB) rs7665090 (OR = 1.15, 95% CI 1.06 to 1.25, P(adj) = 0.01), and IRF8 rs11117432 (OR = 0.75, 95% CI 0.67 to 0.86, P(adj) = 2.49 × 10(−4)) with SSc susceptibility. Furthermore, phenotype stratification showed an association between rs1372072 and rs11117432 with the limited cutaneous subgroup (lcSSc) (P(adj) = 4.45 × 10(−4) and P(adj) = 0.001), whereas rs7665090 was associated with the diffuse cutaneous subtype (dcSSc) (P(adj) = 0.003). Genotype-mRNA expression correlation analysis revealed that the IRF8 protective allele was associated with increased interferon-gamma (IFN-γ) expression (P = 0.03) in patients with SSc but decreased type I IFN (IFIT1) expression in patients and controls (P = 0.02). In addition, we found an epistatic interaction between NF-κB and IRF8 (OR = 0.56, 95% CI 0.00 to 0.74, P = 4 × 10(−4)) which in turn revealed that the IRF8 protective effect is dependent on the presence of the NF-κB susceptibility allele. CONCLUSIONS: An analysis of pleiotropic genes identified two new susceptibility genes for SSc (NF-κB and PLCL2) and confirmed the IRF8 locus. Furthermore, the IRF8 variant influenced the IFN signature, and we found an interaction between IRF8 and NF-κB gene variants that might play a role in SSc susceptibility. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-015-0572-y) contains supplementary material, which is available to authorized users. BioMed Central 2015-03-21 2015 /pmc/articles/PMC4422604/ /pubmed/25880423 http://dx.doi.org/10.1186/s13075-015-0572-y Text en © Arismendi et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Arismendi, Maria Giraud, Matthieu Ruzehaji, Nadira Dieudé, Philippe Koumakis, Eugenie Ruiz, Barbara Airo, Paolo Cusi, Daniele Matucci-Cerinic, Marco Salvi, Erika Cuomo, Giovanna Hachulla, Eric Diot, Elisabeth Caramaschi, Paola Riccieri, Valeria Avouac, Jérôme Kayser, Cristiane Allanore, Yannick Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis |
title | Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis |
title_full | Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis |
title_fullStr | Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis |
title_full_unstemmed | Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis |
title_short | Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis |
title_sort | identification of nf-κb and plcl2 as new susceptibility genes and highlights on a potential role of irf8 through interferon signature modulation in systemic sclerosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422604/ https://www.ncbi.nlm.nih.gov/pubmed/25880423 http://dx.doi.org/10.1186/s13075-015-0572-y |
work_keys_str_mv | AT arismendimaria identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis AT giraudmatthieu identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis AT ruzehajinadira identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis AT dieudephilippe identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis AT koumakiseugenie identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis AT ruizbarbara identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis AT airopaolo identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis AT cusidaniele identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis AT matuccicerinicmarco identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis AT salvierika identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis AT cuomogiovanna identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis AT hachullaeric identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis AT diotelisabeth identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis AT caramaschipaola identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis AT riccierivaleria identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis AT avouacjerome identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis AT kaysercristiane identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis AT allanoreyannick identificationofnfkbandplcl2asnewsusceptibilitygenesandhighlightsonapotentialroleofirf8throughinterferonsignaturemodulationinsystemicsclerosis |